Literature DB >> 11566470

Fibrin sealants in surgical practice: An overview.

M R Jackson1.   

Abstract

The need to effectively manage hemostasis and tissue sealing during surgery has had a strong influence on the development of modern surgical techniques. A group of agents known as surgical tissue adhesives has been developed to promote hemostasis and tissue sealing during surgery, and these comprise both natural and synthetic agents. Fibrin sealants are the most effective tissue adhesives currently available, and they are biocompatible and biodegradable. The fibrin sealants are comprised of purified, virus-inactivated human fibrinogen, human thrombin, and sometimes added components, such as virus-inactivated human factor XIII and bovine aprotinin. These agents mimic the final steps of the physiological coagulation cascade to form a fibrin clot. The use of any plasma-derived product in the surgical setting carries a potential risk of viral transmission. In fact, it was the risk of viral transmission from fibrinogen and thrombin that halted development work on fibrin sealants in the United States. Since that time, new techniques for isolating and concentrating plasma fractions have been developed, and national and international guidelines have been introduced to ensure the safety of all plasma products. All plasma donors are carefully selected and their plasma units screened for viral contamination before processing. All plasma donations and bovine tissue used in the production of commercial fibrin sealants undergo rigorous viral reduction/elimination steps. As a result of this carefully controlled and monitored process, there have been no proven cases of viral transmission associated with the use of commercial fibrin sealant. Fibrin sealants are currently used in a number of surgical specialties, including cardiovascular surgery, thoracic surgery, neurosurgery, plastic and reconstructive surgery, and dental surgery. The use of fibrin sealants has a positive effect on surgical outcomes, such as improved time to hemostasis, reduced blood loss, and reduced complications. This review describes the development of fibrin sealants, the composition of currently available products, and their use in surgical practice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566470     DOI: 10.1016/s0002-9610(01)00770-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  75 in total

1.  Reduction of the closure time of postoperative enterocutaneous fistulas with fibrin sealant.

Authors:  Jorge Avalos-González; Eliseo Portilla-deBuen; Caridad Aurea Leal-Cortés; Abel Orozco-Mosqueda; María del Carmen Estrada-Aguilar; Gabriela Abigail Velázquez-Ramírez; Gabriela Ambriz-González; Clotilde Fuentes-Orozco; Aldo Emmerson Guzmán-Gurrola; Alejandro González-Ojeda
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

3.  A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy.

Authors:  I Galanakis; N Vasdev; N Soomro
Journal:  Rev Urol       Date:  2011

4.  Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms.

Authors:  Walter Geremicca; Carla Fonte; Sisto Vecchio
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

5.  Design of Novel Mixer and Applicator for Two-Component Surgical Adhesives.

Authors:  Kevin Go; Yeong Kim; Andy H Lee; Kelly Staricha; Phillip Messersmith; Matthew Glucksberg
Journal:  J Med Device       Date:  2015-08-06       Impact factor: 0.582

6.  Laparoscopic spray application of fibrin sealant effects on hemodynamics and spray efficiency at various application pressures and distances.

Authors:  K T Druckrey-Fiskaaen; M W W Janssen; L Omidi; N Polze; U Kaisers; I Nur; E Goldberg; G Bokel; J Hauss; Michael R Schön
Journal:  Surg Endosc       Date:  2007-02-21       Impact factor: 4.584

7.  The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion.

Authors:  Michael J Gardner; Demetris Demetrakopoulos; Paul R Klepchick; Pekka A Mooar
Journal:  Int Orthop       Date:  2006-07-01       Impact factor: 3.075

8.  Protection of intestinal anastomosis with biological glues: an experimental randomized controlled trial.

Authors:  S Giuratrabocchetta; M Rinaldi; F Cuccia; M Lemma; D Piscitelli; P Polidoro; D F Altomare
Journal:  Tech Coloproctol       Date:  2011-01-25       Impact factor: 3.781

9.  Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis.

Authors:  Patrick Vavken; Shilpa M Joshi; Martha M Murray
Journal:  Knee       Date:  2010-01-18       Impact factor: 2.199

10.  Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility.

Authors:  Rachel M Smith; Ariella Shikanov; Ekaterina Kniazeva; Deepa Ramadurai; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.